Spotlight Growth
No Result
View All Result
Saturday, August 13, 2022
  • Login
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener
No Result
View All Result
No Result
View All Result
Home Bio/Med/Pharma

Kadmon Holdings, Inc. (NASDAQ: KDMN) Soars After $1.9 Billion Sanofi (NASDAQ: SNY) Takeover Deal

by admin
September 8, 2021
in Bio/Med/Pharma
0
Kadmon NASDAQ KDMN Sanofi NASDAQ SNY Merger Spotlight Growth

Kadmon NASDAQ KDMN Sanofi NASDAQ SNY Merger Spotlight Growth

Kadmon Holdings, Inc. (NASDAQ: KDMN) is engaged as a biopharmaceutical company, which is focused on the research, discovery, and development of novel therapeutics for a range of unmet medical needs. The company’s Rezurock product is an oral tablet designed to treat patients with chronic graft-versus-host disease (cGVHD).

Shares of the biopharma company are soaring 73% during early trading on Wednesday, September 8, 2021. Over the past three months, Kadmon has seen average daily volume of 3.75 million shares. However, volume of 45.17 million shares or dollar volume of $412.85 million, has already exchanged hands through the first hour of trading on Wednesday.

The biopharmaceutical company saw shares soar after the company entered into a definitive merger agreement with France’s Sanofi (NASDAQ: SNY). Kadmon shareholders will receive $9.50 per share in cash, giving the transaction a value of $1.9 billion. This represents a 79% premium compared to the closing price on September 7, 2021 and a 113% premium over the 60-day volume weighted average price.

The Kadmon acquisition comes as Sanofi looks to continue growing its general medicines core assets. The recently FDA-approved Rezurock will be added to Sanofi’s existing transplant portfolio comprised of Thymoglobulin and Mozobil. Thymoglobulin is a polyclonal, anti-human thymocyte antibody and Mozobil is a hematopoietic stem cell mobilizer.

“We are excited that Sanofi has acknowledged the value of Rezurock and the deep potential of our pipeline,” said Harlan Waksal, M.D., President and Chief Executive Officer, Kadmon. “By leveraging Sanofi’s global resources and long-standing expertise in developing and commercializing innovative medicines, Rezurock is now well positioned for global accessibility, faster. I want to thank the entire Kadmon team, including management and the Board of Directors, and the Sanofi organization, for their ongoing commitment to patients and their caregivers.”

Disclosure: Neither Matt Rego nor Spotlight Growth have any position or relationship with any companies mentioned in this article. No payment was made to create this article. This article should not be taken as a solicitation or recommendation to buy or sell any securities. Please conduct your own research and consult your financial advisor to determine your risk tolerance and investment path. We are not licensed brokers or investment advisors.

Tags: acquisitionbiopharmaceuticalsbiotechCNBCcommon stockday tradingemerging growthFox Businessinvestinginvesting newsinvestmentKadmonKadmon stockKDMNmedicalMergermicrocap stocksNASDAQnewspharmaceuticalspublic companyRezurockRobinhoodrobinhood stockssalesSanofiservicessmall cap companiessmall cap stockssmall capsSNYSpotlight GrowthSpotlight Growth Stocksstock marketstock traderstocksstocks to watchswing tradingtakeovertrader newstradingtreatmentwebull
Plugin Install : Widget Tab Post needs JNews - View Counter to be installed
  • Trending
  • Comments
  • Latest
Siyata Mobile NASDAQ SYTA SYTAW SD7 VK7 Purchase Orders Spotlight Growth

New Purchase Orders for SD7 Rugged Device, VK7, and Other Accessories Boost Siyata Mobile’s Outlook (NASDAQ: SYTA)

December 14, 2021
Telcoin TEL Crypto Spotlight Growth

Telcoin (TEL) Quietly Leads a Crypto Remittance Revolution

June 15, 2021
Decentraland (MANA) is the Proof of Concept for the Emerging Metaverse

Decentraland (MANA) is the Proof of Concept for the Emerging Metaverse

November 22, 2021
Alfi NASDAQ ALF Ridesharing Tablet Rollout Spotlight Growth

Alfi, Inc. (NASDAQ: ALF) Climbs 51% After Entering Into Agreement with Miami-Based Fulfillment & Distribution Center For its Ridesharing Digital Tablet Rollout

June 15, 2021
Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

0
Safe-T SFET NASDAQ UN Presentation

Safe-T (NASDAQ: SFET) Has Been Selected to Present at the United Nations’ Office of Information and Communications Technology Event

0
Safe-T Group SFET Q4 FY 2020 Financial Results

Safe-T Group (NASDAQ: SFET) Reports Fourth Quarter and Full Year 2020 Financial Results

0
Safe-T Group NASDAQ SFET FY 2020 Prelim

Safe-T Group Ltd. (NASDAQ: SFET) Estimates Record-High Annual Revenues of Approximately $4.9 Million Representing ~50% Growth YoY 2020

0
Twin Vee PowerCats NASDAQ VEEE Q2 2022 Financial Results Spotlight Growth

Twin Vee PowerCats (NASDAQ: VEEE) Releases Q2 2022 Results Showing 158% Increase in Revenue, Completes Spin-Off of Forza X1 (NASDAQ: FRZA)

August 12, 2022
Is Uber Technologies NYSE UBER Finally Investible Spotlight Growth

Is Uber (NYSE: UBER) Finally Investable?

August 11, 2022
Vacasa NASDAQ VCSA Q2 2022 Financial Results Spotlight Growth

Vacasa (NASDAQ: VCSA) Releases Second Quarter 2022 Financial Results Showing 31% Revenue Growth, Raises Full-Year 2022 Guidance After Strong Results

August 11, 2022
Allied Corp OTCQB ALID Shipment of Colombia Cannabis to Switzerland Spotlight Growth

Allied Corp (OTCQB: ALID) Successfully Ships 1728kgs of Colombian-Grown Commercial Cannabis Flower to Switzerland

August 11, 2022

Recent News

Twin Vee PowerCats NASDAQ VEEE Q2 2022 Financial Results Spotlight Growth

Twin Vee PowerCats (NASDAQ: VEEE) Releases Q2 2022 Results Showing 158% Increase in Revenue, Completes Spin-Off of Forza X1 (NASDAQ: FRZA)

August 12, 2022
Is Uber Technologies NYSE UBER Finally Investible Spotlight Growth

Is Uber (NYSE: UBER) Finally Investable?

August 11, 2022

Categories

  • Bio/Med/Pharma
  • Cannabis
  • Commodities
  • Consumer Goods
  • Crowdfunding
  • Crypto Cheat Sheets
  • Cryptocurrency
  • Earnings
  • Entertainment
  • Financials
  • Market News
  • Opinion
  • Politics
  • Real Estate
  • Split Watch
  • Sponsored
  • Store
  • Technology
  • Uncategorized
  • Venture Capital/Private Equity (VC/PE)

Site Navigation

  • Disclosures
  • Terms Of Service
  • Privacy Policy
  • Contact Us
Spotlight Growth

Copyright © 2021 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.

No Result
View All Result
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener

Copyright © 2021 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Newsletter Signup

Subscribe to our weekly newsletter below and never miss the latest small/micro-cap analysis and investment news from Spotlight Growth.

Enter your email address

Thanks, I’m not interested